Furer V - Search Results

1

Clinical Characterization and Prognostic Risk Factors of Susac Syndrome: A Retrospective Multicenter Study.

Fuchs L, Wilf-Yarkoni A, Kolb H, Vigiser I, Regev K, Zur D, Habot-Wilner Z, Oron Y, Furer V, Shimon N, Hellmann MA, Lotan I, Auriel E, Rennebohm R, Elkayam O, Karni A. Fuchs L, et al. Among authors: furer v. Neurol Neuroimmunol Neuroinflamm. 2025 Mar;12(2):e200357. doi: 10.1212/NXI.0000000000200357. Epub 2024 Dec 18. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 39693597 Free PMC article.

2

Interplay between conformational flexibility, intermolecular H-bonding and 3d-metal cation extraction ability in a series of thiacalix[4]arene lower rim disubstituted Schiff base derivatives.

Strelnikova IV, Ovsyannikov AS, Gubaidullin AT, Agarkov AS, Kleshnina SR, Iova AA, Furer VL, Vandyukov AE, Solovieva SE, Antipin IS. Strelnikova IV, et al. Among authors: furer vl. Phys Chem Chem Phys. 2024 Dec 18;27(1):206-217. doi: 10.1039/d4cp03393k. Phys Chem Chem Phys. 2024. PMID: 39629713

3

Longitudinal safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in children aged 4-11 years with juvenile-onset autoimmune inflammatory rheumatic diseases: A prospective multicenter study.

Eviatar T, Ziv A, Oved A, Miller-Barmak A, Pappo A, Livny R, Amarilyo G, Aviel YB, Naor R, Pel S, Furer V, Elkayam O, Uziel Y, Heshin-Bekenstein M. Eviatar T, et al. Among authors: furer v. Vaccine. 2024 Dec 2;42(26):126426. doi: 10.1016/j.vaccine.2024.126426. Epub 2024 Oct 17. Vaccine. 2024. PMID: 39423454

4

Current and future advances in practice: SAPHO syndrome and chronic non-bacterial osteitis (CNO).

Furer V, Kishimoto M, Tomita T, Elkayam O, Helliwell PS. Furer V, et al. Rheumatol Adv Pract. 2024 Oct 14;8(4):rkae114. doi: 10.1093/rap/rkae114. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 39411288 Free PMC article. Review.

5

A novel inhibitory pathway of synovial inflammation exerted by glucocorticoids and tumor necrosis factor inhibitors via lymphocyte activation gene-3 up-regulation: an ex-vivo study.

Gertel S, Polachek A, Eviatar T, Elkayam O, Furer V. Gertel S, et al. Among authors: furer v. Rheumatology (Oxford). 2024 Jul 25:keae389. doi: 10.1093/rheumatology/keae389. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39052869

6

Mitochondrial structural alterations in fibromyalgia: a pilot electron microscopy study.

Israel L, Furer V, Levin-Zaidman S, Dezorella N, Brontvein O, Ablin JN, Gross A. Israel L, et al. Among authors: furer v. Clin Exp Rheumatol. 2024 Jun;42(6):1215-1223. doi: 10.55563/clinexprheumatol/3l0ihz. Epub 2024 Jun 28. Clin Exp Rheumatol. 2024. PMID: 38966946 Free article.

7

Ex-vivo Cell-based Assay for Assessment of Response to TNF Inhibitors in Patients with Rheumatic Diseases.

Gertel S, Rokach M, Polachek A, Levartovsky D, Broyde A, Furer V, Dovrat TO, Wollman J, Pel S, Neufeld Y, Elkayam O. Gertel S, et al. Among authors: furer v. Rheumatology (Oxford). 2024 May 25:keae309. doi: 10.1093/rheumatology/keae309. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38796682

8

Identification of autoantibodies against PsoP27 in synovial fluid derived from psoriatic arthritis and rheumatoid arthritis patients.

Slobodkin M, Polachek A, Furer V, Elkayam O, Gertel S. Slobodkin M, et al. Among authors: furer v. Scand J Clin Lab Invest. 2024 May;84(3):211-217. doi: 10.1080/00365513.2024.2352844. Epub 2024 May 20. Scand J Clin Lab Invest. 2024. PMID: 38767606 Free article.

9

Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis: Overview of Therapies and a Personalized Approach to Optimized Combined Therapy.

Rose N, Furer V, Polachek A, Elkayam O, Gertel S. Rose N, et al. Among authors: furer v. Eur J Rheumatol. 2024 Jan 11;11(1):27-32. doi: 10.5152/eurjrheum.2024.23091. Online ahead of print. Eur J Rheumatol. 2024. PMID: 38477323 Free PMC article.

10

Real-World Coverage With Influenza, Pneumococcal, and Herpes Zoster Vaccines Among Patients With Rheumatic Diseases in a Nationwide Healthcare Plan.

Furer V, Weil C, Chodik G, Slav SA, Blonder SN, Fisher-Shoval Y, Barak M, Elkayam O. Furer V, et al. J Rheumatol. 2024 May 1;51(5):505-516. doi: 10.3899/jrheum.2023-0867. J Rheumatol. 2024. PMID: 38302167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters